As Genfit hopes to get its liver drug on the market, founding CEO makes way for new blood

As Genfit hopes for phase 3 successes and filings for its liver disease drug, its long-term CEO and co-founder Jean-François Mouney is stepping aside and promoting his executive vice president of marketing and commercial development to the top job.